SCHEMBL14143168

SCHEMBL14143168

O=Cc1nc(-c2ccc(F)cc2)c2ccccn12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.58
▸ RAD51 Q06609 4/20 0.45
▸ KDM4E B2RXH2 6/20 0.43
▸ HPGD P15428 3/20 0.43
▸ GAA P10253 3/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ NPC1 O15118 2/20 0.42
▸ RAB9A P51151 2/20 0.42
▸ POLB P06746 2/20 0.42
▸ MEN1 O00255 4/20 0.41
▸ KMT2A Q03164 4/20 0.41
▸ MAPT P10636 2/20 0.41
▸ EGFR P00533 1/20 0.41
▸ RAF1 P04049 1/20 0.41
▸ ADORA3 P0DMS8 1/20 0.41
▸ ADORA2A P29274 1/20 0.41
▸ ADORA2B P29275 1/20 0.41
▸ ADORA1 P30542 1/20 0.41
▸ GSK3B P49841 1/20 0.41
▸ MAPK14 Q16539 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31215221 0.85 HIF1A (0.52) ALDH1A1RAD51KDM4EHPGDGAA
SCHEMBL4326394 0.77 RORC (0.57) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL18031314 0.74 MAP2K3 (0.54) ALDH1A1RAD51KDM4EHPGDMEN1
SCHEMBL31612337 0.74 RAD51 (0.72) ALDH1A1RAD51KDM4EHPGDMAPT
SCHEMBL21360469 0.73 ALDH1A1 (1.00) ALDH1A1KDM4EHPGDGAANPC1
SCHEMBL18033605 0.72 RORC (0.53) ALDH1A1RAD51KDM4EHPGDMEN1
SCHEMBL7038860 0.71 RAD51 (0.49) ALDH1A1RAD51KDM4EHPGDGAA
SCHEMBL20674509 0.71 ALDH1A1 (0.42) ALDH1A1KDM4EHPGDGAAL3MBTL1
SCHEMBL29390070 0.70 RORC (0.59) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL1429286 0.70 ALDH1A1 (0.67) ALDH1A1KDM4EHPGDGAANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008085302-A1 IMIDAZOPYRIDINE ANALOGS AS CB2 RECEPTOR MODULATORS, USEFUL IN THE TREATMENT OF PAIN, RESPIRATORY AND NON-RESPIRATORY DISEASES MERCK & CO., INC. (US) 2008-07-17 — — WO disclosed
Send feedback